The Inter-ministerial Conference on Public Health andthe Government Commissioner for Corona give more details on the vaccination strategy.
News FAMHP
There are 36 result(s) found based on your search criteria
1-10 from 36 result(s)
Flash VIG-news: ESMYA® (ulipristal acetate 5 mg): revocation of the marketing authorisation
After reviewing the benefit-risk ratio of the medicinal product ESMYA®, the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) has recommended the definitive revocation of its marketing authorisation (MA).
Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages
On 1 April 2020, the FAMHP took steps regarding a range of medicinal products in order to avoid any shortage. These measures have now been extended by one month.
Influenza vaccine: the FAMHP carries out a survey among all pharmacies
The FAMHP continues to closely monitor the distribution of influenza vaccines and is currently conducting a survey among all pharmacies to determine to what extent the planned supply will be enough.
Influenza vaccine: one million doses are still expected and will be distributed to pharmacies between late October and early November
The FAMHP will continue to closely monitor their distribution. In order to provide patients, doctors and pharmacists with the best possible information, the FAMHP collected the most up-to-date information from the three authorisation holders concerned (Sanofi, Mylan, GSK) on the planned delivery dates to wholesaler-distributors. According to this, approximately one third of the planned vaccines must still be delivered.
Influenza vaccine: 10% of the stocks already distributed to the patients, two thirds still to be distributed to (hospital) pharmacies
The FAMHP makes a first assessment of the situation regarding the distribution of flu vaccines. More than half of the vaccines have yet to be placed on the market.
Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages
On 1 April 2020, the FAMHP took steps regarding a range of medicinal products in order to avoid any shortage. These measures have now been extended by one month.
Gardasil, vaccine against HPV (Human Papillomaviruses), is available again
After a period of limited availability, the Gardasil 9 vaccine, used to prevent Human Papillomaviruses (HPV), is available to everyone again.
Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages
On 1 April 2020, the FAMHP took steps regarding a range of medicinal products in order to avoid any shortage. These measures have now been extended by one month.
Coronavirus and the fight led by the FAMHP: rigorous work to ensure each patient receives the treatment they need
Since the start of the coronavirus pandemic, the FAMHP teams have been working relentlessly to support hospitals and pharmacies facing difficulties in securing supplies of medicinal products. Here is an overview of the measures put in place by the FAMHP to guarantee stocks of medicinal products in Belgium.